During this activity, attendees will learn:

• IgA is the predominant antibody in mucosal secretions
• The benefits of adding an adjuvant or adjuvant combinations to a vaccine formulation
• Differences in vaccine-induced immune responses induced by intramuscular immunization when compared to intranasal immunization
• The benefit of vaccine-induced mucosal IgA for protection against respiratory pathogens